Your Health, We Care
Most common (>20%) adverse reactions, including laboratory abnormalities were leukopenia, lymphopenia, thrombocytopenia, diarrhea, anemia, rash, musculoskeletal pain, nail toxicity, neutropenia, dry skin, stomatitis, fatigue, and cough.
from FDA，2022.10
The development of cancer treatment drugs has brought hope to patients, but it h···【more】
Release date：2025-03-10Recommended：149
Osimertinib is a targeted therapy that plays an important role in the treatment ···【more】
Release date：2025-03-07Recommended：198
Osimertinib is an important drug for the treatment of non-small cell lung cancer···【more】
Release date：2025-03-07Recommended：148
